What is a stock summary page? Click here for an overview.
Business Description
FibroBiologics Inc
NAICS : 541713
SIC : 2833
Description
FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 5.01 | |||||
| Equity-to-Asset | 0.26 | |||||
| Debt-to-Equity | 0.57 | |||||
| Debt-to-EBITDA | -0.09 | |||||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 36.27 | |||||
| 9-Day RSI | 37.15 | |||||
| 14-Day RSI | 35.77 | |||||
| 3-1 Month Momentum % | -51.82 | |||||
| 6-1 Month Momentum % | -62.14 | |||||
| 12-1 Month Momentum % | -90.09 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.23 | |||||
| Quick Ratio | 1.23 | |||||
| Cash Ratio | 1.17 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -15.42 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -1073.87 | |||||
| ROA % | -159.03 | |||||
| ROIC % | -149.3 | |||||
| ROC (Joel Greenblatt) % | -731.51 | |||||
| ROCE % | -607.98 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 12.18 | |||||
| Price-to-Tangible-Book | 11.69 | |||||
| EV-to-EBIT | -1.59 | |||||
| EV-to-Forward-EBIT | -3 | |||||
| EV-to-EBITDA | -1.65 | |||||
| EV-to-FCF | -2.69 | |||||
| Price-to-Net-Current-Asset-Value | 93.5 | |||||
| Earnings Yield (Greenblatt) % | -62.89 | |||||
| FCF Yield % | -29.28 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
FibroBiologics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.503 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 144.37 | ||
| 14-Day RSI | 35.77 | ||
| 14-Day ATR (€) | 0.046926 | ||
| 20-Day SMA (€) | 0.991 | ||
| 12-1 Month Momentum % | -90.09 | ||
| 52-Week Range (€) | 0.89 - 11.8 | ||
| Shares Outstanding (Mil) | 36.41 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
FibroBiologics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
FibroBiologics Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
FibroBiologics Inc Frequently Asked Questions
What is FibroBiologics Inc(STU:SG0)'s stock price today?
The current price of STU:SG0 is €0.94. The 52 week high of STU:SG0 is €11.80 and 52 week low is €0.89.
When is next earnings date of FibroBiologics Inc(STU:SG0)?
The next earnings date of FibroBiologics Inc(STU:SG0) is 2025-05-30 Est..
Does FibroBiologics Inc(STU:SG0) pay dividends? If so, how much?
FibroBiologics Inc(STU:SG0) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers